Helius - Latest News [Page 1]

Cannabis for pets, a first for New Zealand

Thursday, 21 May 2020, 9:55 am | Helius

Local company, Helius Group, is launching New Zealand’s first ever medicinal cannabis for pets’ product range with the establishment of Helius Animal Health. The new business will operate alongside the country’s largest medicinal cannabis company, ... More >>

Helius appoints Chief Quality Officer

Friday, 14 February 2020, 9:33 am | Helius

His previous role was with contract medicines manufacturer, Argenta, where he was Global Head of Quality, with responsibility for quality and GMP compliance at the company’s US, UK, and New Zealand sites. More >>

Legalised personal cannabis use would be tightly regulated

Thursday, 5 December 2019, 2:55 pm | Helius

The Government’s approach to legalising personal cannabis use would provide many opportunities for new businesses, boost tax revenue, and deliver quality standards in a safer and more open environment. As the proposed legislation’s name suggests, ... More >>

Tracking survey: Support lifts for personal cannabis use

Sunday, 1 December 2019, 12:11 pm | Helius

Support for legalising personal cannabis use has risen by 9% in the past quarter, according to the country’s only 12-month tracking survey on how New Zealanders would vote in the Government's binding referendum next year. More >>

Helius appoints Group Financial Controller

Monday, 18 November 2019, 10:29 am | Helius

Mr Williams has joined New Zealand’s largest medicinal cannabis company after holding a number of financial leadership roles - from managing high-growth start-ups to serving as Chief Financial Officer of a well-established NZX-listed company. More >>

Leading pain specialist’s cannabis role

Monday, 4 November 2019, 2:29 pm | Helius

“The appointment of a leading pain specialist to New Zealand’s largest licensed medicinal cannabis company is great news for the many Kiwis suffering from chronic pain,” says Paul Manning, Co-Chief Executive of Helius Therapeutics. More >>

Helius appoints Quality Manager

Monday, 14 October 2019, 12:10 pm | Helius

Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well as the quality of all manufactured medicinal cannabis products. More >>

Helius appoints Quality Manager

Monday, 14 October 2019, 9:42 am | Helius

Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well as the quality of all manufactured medicinal cannabis products. More >>

Support to legalise recreational cannabis in decline

Saturday, 17 August 2019, 10:38 am | Helius

The prospect of ending wider cannabis prohibition looks increasingly unlikely. Over the last nine months, the percentage of New Zealanders who would vote for legalising the personal use of cannabis has declined at a near linear rate of around 10% per ... More >>

Medicinal cannabis advocates need to have their say today

Wednesday, 7 August 2019, 10:33 am | Helius

With public consultation closing tonight, the country’s largest licensed medicinal cannabis company, Helius Therapeutics, is urging Kiwis to have their say on the Ministry of Health’s discussion document for New Zealand’s Medicinal Cannabis Scheme. More >>

Specialist sign-off for cannabis would strain health sector

Friday, 2 August 2019, 12:35 pm | Helius

An independent survey of over 700 healthcare professionals reveals genuine concern that New Zealand’s health sector would struggle to cope if ‘specialist sign-off’ is required before a GP can prescribe medicinal cannabis. More >>

Specialist sign-off for cannabis would strain health sector

Friday, 2 August 2019, 12:06 pm | Helius

An independent survey of over 700 healthcare professionals reveals genuine concern that New Zealand’s health sector would struggle to cope if ‘specialist sign-off’ is required before a GP can prescribe medicinal cannabis. More >>

Visiting cannabis expert warns against specialist sign-off

Sunday, 21 July 2019, 12:09 pm | Helius

“The prospect of a specialist recommendation being required before a GP can prescribe medicinal cannabis would be a huge error for New Zealand,” says British neurologist and Europe’s pre-eminent medicinal cannabis expert, Professor Mike Barnes. More >>

Cannabis scheme heading in the right direction

Thursday, 11 July 2019, 8:53 am | Helius

“New Zealanders fought hard to achieve strong parliamentary support for medicinal cannabis last year. It’s now really important people have their say on the design of the regulations to ensure sound and sensible patient access,” says Paul Manning, ... More >>

Cannabis scheme heading in the right direction

Wednesday, 10 July 2019, 6:30 pm | Helius

“New Zealanders fought hard to achieve strong parliamentary support for medicinal cannabis last year. It’s now really important people have their say on the design of the regulations to ensure sound and sensible patient access,” says Paul Manning, ... More >>

Groundswell of demand for medicinal cannabis, reveals poll

Sunday, 19 May 2019, 3:44 pm | Helius

Over 400,000 New Zealanders say they would definitely seek out medicinal cannabis products when they become widely available from 2020, according to a large independent survey and the first of its kind, just released. More >>

Helius appoints world leader in medical cannabis R&D

Friday, 12 April 2019, 10:05 am | Helius

Dr James Polston has been announced as Scientific Director at Helius Therapeutics, leaving the United States where he was a leader of research and development at the world’s largest medicinal cannabis company, by revenue. More >>

Helius Therapeutics appoints pharmaceuticals leader

Wednesday, 13 March 2019, 10:17 am | Helius

New Zealand’s largest licensed medicinal cannabis company, Helius Therapeutics, has appointed senior pharmaceuticals industry leader Mitch Cuevas to its team as Director and Senior Advisor. More >>

News of UN cannabis classification downgrade welcomed

Sunday, 3 February 2019, 11:13 am | Helius

A World Health Organisation report to the United Nations on the classification of cannabis could help boost exports, says New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics. More >>

Cannabis referendum would pass comfortably: poll

Wednesday, 9 January 2019, 9:45 am | Helius

An independent survey of nearly 1,000 New Zealanders reveals the Government's 2020 referendum on recreational cannabis use would gain 60% support. More >>

 

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL